New generation vaccines:
Saved in:
| Format: | Book |
|---|---|
| Language: | English |
| Published: |
New York [u.a.]
Dekker
1997
|
| Edition: | 2. ed., rev. and expanded |
| Subjects: | |
| Online Access: | Inhaltsverzeichnis |
| Physical Description: | XVI, 1214 S. Ill., graph. Darst. |
| ISBN: | 0824700619 |
Staff View
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV012270608 | ||
| 003 | DE-604 | ||
| 005 | 19981120 | ||
| 007 | t | ||
| 008 | 981118s1997 ad|| |||| 00||| eng d | ||
| 020 | |a 0824700619 |9 0-8247-0061-9 | ||
| 035 | |a (OCoLC)36682381 | ||
| 035 | |a (DE-599)BVBBV012270608 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-20 | ||
| 050 | 0 | |a QR189 | |
| 082 | 0 | |a 615/.372 |2 21 | |
| 084 | |a XD 3300 |0 (DE-625)152554:12905 |2 rvk | ||
| 245 | 1 | 0 | |a New generation vaccines |c ed. by Myron M. Levine ... |
| 250 | |a 2. ed., rev. and expanded | ||
| 264 | 1 | |a New York [u.a.] |b Dekker |c 1997 | |
| 300 | |a XVI, 1214 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 650 | 7 | |a Antigenen |2 gtt | |
| 650 | 7 | |a Infectieziekten |2 gtt | |
| 650 | 7 | |a Vaccins |2 gtt | |
| 650 | 7 | |a Vacinas |2 larpcal | |
| 650 | 4 | |a Vaccines | |
| 650 | 0 | 7 | |a Impfstoff |0 (DE-588)4026655-2 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Impfstoff |0 (DE-588)4026655-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Levine, Myron Max |e Sonstige |4 oth | |
| 856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008316561&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-008316561 | ||
Record in the Search Index
| _version_ | 1804126890856808448 |
|---|---|
| adam_text | Contents
Preface Hi
Contributors x
Part I: Introduction to Vaccinology
1. Vaccines and Vaccination in Historical Perspective 1
Myron M. Levine and Rosanna Lagos
2. The Traditional Vaccines: An Overview 13
Gordon L. Ada
3. An Overview of Biotechnology as Applied to Vaccine Development 25
Graeme C. Woodrow
4. Initial Clinical Evaluation of New Vaccine Candidates: Phase 1 and 2 Clinical Trials of Safety,
Immunogenicity, and Preliminary Efficacy 35
Carol 0. Jacket, Martha J. Mattheis, and Margaret Baker Rennels
5. Long Term Evaluation of Vaccine Protection: Methodological Issues for Phase 3 Trials and
Phase 4 Studies 47
John D. Clemens, Abdollah Naficy, and Malta R. Rao
6. Economic Analyses of Vaccines and Vaccination Programs: Evaluating the Economic Rationale
for Immunization 69
Orin S. Levine and Benjamin Schwartz
7. Reaping the Benefits: Getting Vaccines to Those Who Need Them 79
J. W. Lee, Bruce Aylward, Harry F. Hull, Amie Batson, Maureen E. Birmingham, and John Lloyd
8. Progress and Challenges in Modern Vaccinology: An Immunologist s Perspective 89
Gustav J. V. Nossal
9. The Eradication of Vaccine Preventable Diseases 93
William Foege
Part II: Molecular Immunology as Applied to Vaccine Development
10. Recent Advances in Immunology: Impact on Vaccine Development 99
Marcelo B. Sztein and Graham F. Mitchell
11. Computer Prediction of T Cell Epitopes 127
Anne S. De Groot, Gabriel E. Meister, James L. Cornette, Hanah Margalit, Charles DeLisi, and
Jay A. Berzofsky
12. Identification of B and T Cell Epitopes Through Structural Characterization and Peptide Technology .. 139
Juan A. Cooper and Allan J. Saul
v
vi • Contents
13. The Gastrointestinal Mucosal Immune System 151
Stephen P. James
Part III: Immunopotentiation, Adjuvants, Nonliving Antigen Delivery Systems, and
Naked DNA Vaccines
14. Adjuvants for the Future 173
Robert Edelman
15. Proteosomes for Improved Nasal, Oral, or Injectable Vaccines 193
George H. Lowell
16. Liposomes as Adiuvants for Vaccines 207
Carl R. Alving
17. Prospects for the Development of New and Improved Vaccines Through the Use of
Microencapsulation Technology 215
Derek T. O Hagan
18. Antigen Cochleate Preparations for Oral and Systemic Vaccination 229
Raphael J. Mannino and Susan Gould Fogerite
19. Ty Virus like Particles as an Antigen Delivery System 239
Guy T. Layton
20. Immunopotentiating Reconstituted Influenza Virosomal Vaccine Delivery System 247
Reinhard Gliick and Stanley J. Cryz, Jr.
21. Mutant Pertussis and Escherichia coli Heat Labile Toxins as Adjuvants for Enhancing Local and
Systemic Immune Responses to Coadministered, Nonliving Antigens 253
Gillian Douce, Gordon Dougan, MariaGrazia Pizza, Rino Rappuoli, and Mark Roberts
22. Oral Vaccine Production in the Edible Tissues of Transgenic Plants 263
Charles J. Arntzen and Hugh S. Mason
23. DNA Based Vaccines: Extending the Technology 279
Stephen Albert Johnston, Kathryn F. Sykes, and Michael A. Barry
24. Vaccination Against Influenza with Plasmid DNA: Cross Strain and Homologous Protection 287
John J. Donnelly, Jeffrey B. Ulmer, and Margaret A. Liu
Part IV: Live Antigen Delivery Systems
25. Vaccinia Virus as a Live Vector for Expression of Immunogens 297
Charles Flexner and Bernard Moss
26. Attenuated Poliovirus as Live Vector 315
Matthias Gromeier, Hui Hua Lu, Steffen Mueller, Eckard Wimmer, and Louis Alexander
27. Attenuated Salmonella as a Live Vector for Expression of Foreign Antigens 331
i. Expressing Bacterial Antigens 331
5. N. Chatfield and Gordon Dougan
ii. Carrying Viral Antigens 343
Florian Schodel
iii. Salmonella Expressing Protozoal Antigens 351
Myron M. Levine, James E. Galen, Marcelo B. Sztein, Magda Beier, and Fernando Noriega
Contents • vij
28. BCG as a Recombinant Vaccine Vector 363
Glenn J. Fennelly, William R. Jacobs, Jr., and Barry R. Bloom
29. Attenuated Vibrio cholerae as a Live Vector for Expression of Foreign Antigens 379
Joan R. Butterton and Stephen B. Calderwood
Part V: New and Improved Vaccines Against Diseases for Which There Already Exist Licensed Vaccines
30. New and Improved Vaccines Against Pertussis 387
Erik L. Hewlett and James D. Cherry
31. New and Improved Vaccines Against Diphtheria and Tetanus 417
Rino Rappuoli
32. Progress in Development of New Attenuated Strains of Salmonella typhi as Live Oral Vaccines
Against Typhoid Fever 437
Myron M. Levine, Carol O. Tacket, James E. Galen, Eileen M. Barry, S. N. Chatfield, Gordon Dougan,
Fernando Noriega, and Marcelo B. Sztein
33. New and Improved Vaccines Against Cholera 447
i. Attenuated Vibrio cholerae 01 and 0139 Strains as Live Oral Cholera Vaccines 447
James B. Kaper, Carol 0. Tacket, and Myron M. Levine
ii. Oral B Subunit Killed Whole Cell Cholera Vaccine 459
Jan Holmgren, Marianne Jertborn, and Ann Mari L. Svennerholm
34. New and Improved Vaccines Against Meningococcal Disease 469
Wendell D. Zollinger
35. Epidemiological Impact of Conjugate Vaccines on Invasive Disease Caused by Haemophilus influenzae
Type b 489
Jay D. Wenger, Robert Booy, Paul T. Heath, and Richard Moxon
36. Conjugate Vaccines Against Streptococcus pneumoniae 503
David L. Klein and Ronald W. Ellis
37. Vaccine Development for Rickettsial Infections: Rocky Mountain Spotted Fever, Epidemic Typhus,
and Scrub Typhus 527
Kimberly W. Schuenke and David H. Walker
38. New and Improved Vaccines Against Influenza 545
Mary Lou Clements and Ina Stephens
39. New Vaccines Against Hepatitis A 571
Jack T. Stapleton and Stanley M. Lemon
40. New and Improved Vaccines for Dengue, Japanese Encephalitis, and Yellow Fever Viruses 587
Niranjan Kanesa thasan, Robert Putnak, and Charles H. Hake, Jr.
41. Improved Vaccines Against Rabies 607
Then Fang Fu, Bernhard Dietzschold, Stanley A. Plotkin, and Charles E. Rupprecht
42. Combination Vaccines for Routine Infant Immunization: Prospects, Progress, and Dilemmas 619
Carole Heilman and N. Regina Rabinovich
43. New Vaccines Against Tuberculosis 631
Douglas Young and Uli Fruth
viii • Contents
44. Live Attenuated Varicella Vaccines 647
Michiaki Takahashi and Anne A. Gershon
Part VI: Vaccines Against Diseases for Which Licensed Vaccines Have Not Previously Been Available
(or Which Have Not Been Widely Licensed)
45. Vaccines Against Rotavirus 659
Paul A. Offit, H. Fred Clark, and Albert Z. Kapikian
46. Experimental HIV 1 Vaccines 673
Mary Lou Clements
47. Vaccines Against Respiratory Syncytial Virus and Parainfluenza Virus Type 3 711
James E. Crowe, Jr., Peter L. Collins, Robert M. Chanock, and Brian R. Murphy
48. Herpes Simplex Vaccines 727
Richard J. Whitley
49. Vaccines Against Arenaviruses and Filoviruses 749
J. Christopher S. Clegg and Anthony Sanchez
50. Vaccines Against Papillomavirus Infections 767
Robert W. Tindle and Ian H. Frazer
51. Vaccines Against Streptococcus pyogenes Infections 783
Debra E. Bessen and Vincent A. Fischetti
52. O Specific Polysaccharide Protein Conjugates for Prevention of Enteric Bacterial Diseases 803
John B. Robbins, Rachel Schneerson, and Shousun C. Szu
53. Vaccines Against Gonococcal Infection 817
Timothy A. Mietzner and Myron S. Cohen
54. Vaccines Against Shigella Infections 843
i. Escherichia coli or Salmonella typhi Expressing Shigella Antigens 843
Thomas Larry Hale and Malabi M. Venkatesan
ii. Engineered Attenuated Mutants of Shigella as Live Oral Vaccines 853
Fernando Noriega, Samuel B. Formal, Karen L. Kotloff, and Alf A. Lindberg
55. Vaccines Against Enterotoxigenic Escherichia coli Infections 865
i. Oral Inactivated Vaccines Against Enterotoxigenic Escherichia coli 865
Ann Mari L. Svennerholm, Christina khren, and Marianne Jertborn
ii. Live Oral Vaccines and Subunit (Purified Fimbriae and Toxin Subunit) Vaccines 875
Carol O. Tacket and Myron M. Levine
56. Vaccines Against Campylobacter jejuni 885
Daniel A. Scott, Shahida Baqar, Donald H. Burr, Gary Pazzaglia, and Patricia Guerry
57. Vaccines Against Lyme Disease 897
Robert Edelman
58. Vaccines Against Dental Caries Infection 913
Daniel J. Smith and Martin A. Taubman
59. Vaccines Against Klebsiella, Pseudomonas, and Septicemic E. coli Infections 931
Alan S. Cross and Stanely J. Cryz, Jr.
60. Vaccines Against Escherichia coli and Proteus Urinary Tract Infections 945
Harry L. T. Mobley
Contents • ix
61. Vaccines Against Helicobacter pylori 963
Adrian Lee and Christopher Doidge
62. Vaccines for Staphylococcus aureus Infections 979
AH I. Fattom and Robert B. Naso
63. Vaccines Against Malaria 989
i. Synthetic Peptide Vaccines Against the Sporozoite Stage of Plasmodium 989
Elizabeth H. Nardin and Ruth S. Nussenzweig
ii. Vaccines Designed to Induce Protective T Cell Responses Against
Plasmodium lnfected Hepatocytes 1009
John B. Sacci, Jr., Eileen D. Franke, and Stephen L. Hoffman
iii. Spf66 Vaccine Against Asexual Erythrocytic Stages of P. falciparum 1027
Roberto Amador and Manuel E. Patarroyo
iv. Vaccines Against Asexual Blood Stages of Plasmodium falciparum 1035
Robin F. Anders
v. Vaccines Against Sexual Stage Parasites of P. falciparum: Transmission Blocking Vaccines 1057
David C. Kaslow
64. Vaccines Against Leishmaniasis 1065
Carol L. Eisenberger and Charles L Jaffe
65. Vaccines Against Schistosomiasis 1081
Gilles J. Riveau and Andre Capron
Part VII: Vaccines Against Chronic Diseases, Vaccine Therapy, and Miscellaneous Vaccines
66. Antitumor Vaccines 1095
Karl Erik Hellstrom, Ingegerd Hellstrom, and Lieping Chen
67. Vaccine Therapy 1117
Donald S. Burke
68. Vaccines to Prevent Pregnancy 1131
Vernon C. Stevens and Warren R. Jones
69. An Anti arthropod Vaccine: TickGARD—A Vaccine to Prevent Cattle Tick Infestations 1145
Gary S. Cobon
Part VIII: Commercial and Regulatory Aspects of Vaccine Production and Distribution
70. Large Scale Production of Live Attenuated Bacterial and Viral Vaccines 1153
Stanley J. Cryz, Jr., and Reinhard Gliick
71. Vaccine Development: The Long Road from Initial Idea to Product Licensure 1165
Jens Peter Gregersen
72. Inadvertant Nontarget Effects of Live Vaccines 1179
Myron M. Levine and Eileen M. Barry
73. The Role of the Food and Drug Administration in Vaccine Testing and Licensure 1185
Bascomb F. Anthony and Ann Sutton
Index 7795
|
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV012270608 |
| callnumber-first | Q - Science |
| callnumber-label | QR189 |
| callnumber-raw | QR189 |
| callnumber-search | QR189 |
| callnumber-sort | QR 3189 |
| callnumber-subject | QR - Microbiology |
| classification_rvk | XD 3300 |
| ctrlnum | (OCoLC)36682381 (DE-599)BVBBV012270608 |
| dewey-full | 615/.372 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615/.372 |
| dewey-search | 615/.372 |
| dewey-sort | 3615 3372 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| edition | 2. ed., rev. and expanded |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01388nam a2200409 c 4500</leader><controlfield tag="001">BV012270608</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">19981120 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">981118s1997 ad|| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0824700619</subfield><subfield code="9">0-8247-0061-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)36682381</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV012270608</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-20</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">QR189</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.372</subfield><subfield code="2">21</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XD 3300</subfield><subfield code="0">(DE-625)152554:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">New generation vaccines</subfield><subfield code="c">ed. by Myron M. Levine ...</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">2. ed., rev. and expanded</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York [u.a.]</subfield><subfield code="b">Dekker</subfield><subfield code="c">1997</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XVI, 1214 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Antigenen</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Infectieziekten</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Vaccins</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Vacinas</subfield><subfield code="2">larpcal</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vaccines</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Impfstoff</subfield><subfield code="0">(DE-588)4026655-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Impfstoff</subfield><subfield code="0">(DE-588)4026655-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Levine, Myron Max</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008316561&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-008316561</subfield></datafield></record></collection> |
| id | DE-604.BV012270608 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T18:24:39Z |
| institution | BVB |
| isbn | 0824700619 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-008316561 |
| oclc_num | 36682381 |
| open_access_boolean | |
| owner | DE-20 |
| owner_facet | DE-20 |
| physical | XVI, 1214 S. Ill., graph. Darst. |
| publishDate | 1997 |
| publishDateSearch | 1997 |
| publishDateSort | 1997 |
| publisher | Dekker |
| record_format | marc |
| spelling | New generation vaccines ed. by Myron M. Levine ... 2. ed., rev. and expanded New York [u.a.] Dekker 1997 XVI, 1214 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Antigenen gtt Infectieziekten gtt Vaccins gtt Vacinas larpcal Vaccines Impfstoff (DE-588)4026655-2 gnd rswk-swf Impfstoff (DE-588)4026655-2 s DE-604 Levine, Myron Max Sonstige oth HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008316561&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | New generation vaccines Antigenen gtt Infectieziekten gtt Vaccins gtt Vacinas larpcal Vaccines Impfstoff (DE-588)4026655-2 gnd |
| subject_GND | (DE-588)4026655-2 |
| title | New generation vaccines |
| title_auth | New generation vaccines |
| title_exact_search | New generation vaccines |
| title_full | New generation vaccines ed. by Myron M. Levine ... |
| title_fullStr | New generation vaccines ed. by Myron M. Levine ... |
| title_full_unstemmed | New generation vaccines ed. by Myron M. Levine ... |
| title_short | New generation vaccines |
| title_sort | new generation vaccines |
| topic | Antigenen gtt Infectieziekten gtt Vaccins gtt Vacinas larpcal Vaccines Impfstoff (DE-588)4026655-2 gnd |
| topic_facet | Antigenen Infectieziekten Vaccins Vacinas Vaccines Impfstoff |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008316561&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT levinemyronmax newgenerationvaccines |